When compared to other thromboinflammatory biomarkers from the literature such as S100B, which has been associated with tissue damage, post-stroke infections and consecutively mortality (23), CT-pro-ET-1 predicted overall mortality in ischemic stroke patients independently of known risk factors. The gene discussed is S100B; the disease is ischemic stroke.